0

Idarubicin

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP57852570-A
CAS57852-57-0
Structure
MDL NumberMFCD00866457
Molecular Weight533.95
InChI KeyXDXDZDZNSLXDNA-TZNDIEGXSA-N
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size50MG
1

All-trans-retinoic Acid, Idarubicin, and IV Arsenic Trioxide as Initial Therapy in Acute Promyelocytic Leukemia (APML4)

Harry J Iland, Ken Bradstock, Shane G Supple, Alberto Catalano, Marnie Collins, Mark Hertzberg, Peter Browett, Andrew Grigg, Frank Firkin, Amanda Hugman, John Reynolds, Juliana Di Iulio, Campbell Tiley, etc.

Blood. 2012 Aug 23;120(8):1570-80; quiz 1752.

PMID: 22715121

1

Arsenic Trioxide and All-Trans Retinoic Acid Treatment for Acute Promyelocytic Leukaemia in All Risk Groups (AML17): Results of a Randomised, Controlled, Phase 3 Trial

Alan K Burnett, Nigel H Russell, Robert K Hills, David Bowen, Jonathan Kell, Steve Knapper, Yvonne G Morgan, Jennie Lok, Angela Grech, Gail Jones, Asim Khwaja, Lone Friis, Mary Frances McMullin, Ann Hunter, etc.

Lancet Oncol. 2015 Oct;16(13):1295-305.

PMID: 26384238

1

Doxorubicin

PMID: 31643934

1

Evaluation of Gilteritinib in Combination With Chemotherapy in Preclinical Models of

Yoko Ueno, Masamichi Mori, Yoshiteru Kamiyama, Rika Saito, Naoki Kaneko, Eriko Isshiki, Sadao Kuromitsu, Masahiro Takeuchi

Oncotarget. 2019 Apr 2;10(26):2530-2545.

PMID: 31069015

1

Randomized Study of Induction Therapy Comparing Standard-Dose Idarubicin With High-Dose Daunorubicin in Adult Patients With Previously Untreated Acute Myeloid Leukemia: The JALSG AML201 Study

Shigeki Ohtake, Shuichi Miyawaki, Hiroyuki Fujita, Hitoshi Kiyoi, Katsuji Shinagawa, Noriko Usui, Hirokazu Okumura, Koichi Miyamura, Chiaki Nakaseko, Yasushi Miyazaki, Atsushi Fujieda, Tadashi Nagai, Takahisa Yamane, etc.

Blood. 2011 Feb 24;117(8):2358-65.

PMID: 20693429

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode